# Reviva Pharmaceuticals Holdings, Inc.: Form 8-K, filed Jun 2, 2025

- Company: [Reviva Pharmaceuticals Holdings, Inc.](/companies/rvph.md) (CIK 1742927)
- Form: 8-K
- Filed: 2025-06-02
- Accepted by EDGAR: Jun 2, 2025, 07:05 ET
- Period: 2025-06-02
- Accession: 0001437749-25-019062
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1742927/000143774925019062/rvph20250601_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1742927/000143774925019062/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1742927/000143774925019062/rvph20250601_8k.htm

Filed Jun 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-019062. Last ingested by Listed: Oct 29, 2026, 16:33 ET. No prices; not investment advice.